CL
BIIB icon

Choreo LLC’s Biogen BIIB Stock Holding History

Choreo LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Buy
2,380
+3
+0.1% +$553 0.01% 1019
2025
Q4 		$419K Sell
2,377
-67
-3% -$10.9K 0.01% 1010
2025
Q3 		$342K Buy
2,444
+773
+46% +$104K ﹤0.01% 1151
2025
Q2 		$210K Buy
+1,671
New +$208K ﹤0.01% 1377
2025
Q1 		– Sell
-1,360
Closed -$205K – 1470
2024
Q4 		$205K Sell
1,360
-422
-24% -$71.2K ﹤0.01% 1422
2024
Q3 		$340K Buy
1,782
+502
+39% +$105K 0.01% 1128
2024
Q2 		$297K Buy
+1,280
New +$278K 0.01% 1101
2018
Q3 		– Sell
-977
Closed -$284K – 225
2018
Q2 		$284K Buy
977
+135
+16% +$38K 0.04% 190
2018
Q1 		$231K Sell
842
-14
-2% -$4.35K 0.03% 250
2017
Q4 		$273K Buy
+856
New +$275K 0.03% 233
2016
Q4 		– Sell
-1,270
Closed -$398K – 265
2016
Q3 		$398K Buy
1,270
+66
+5% +$19.5K 0.07% 140
2016
Q2 		$291K Buy
1,204
+329
+38% +$86.7K 0.06% 158
2016
Q1 		$228K Buy
+875
New +$231K 0.05% 175
2014
Q2 		– Sell
-942
Closed -$288K – 148
2014
Q1 		$288K Buy
+942
New +$299K 0.08% 109

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Choreo LLC's BIIB Position: Q1 2026 in Review

Choreo LLC increased its Biogen (BIIB) stake by 0.13% in Q1 2026, buying an estimated $553 and bringing the position to 2,380 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #1019.

Choreo LLC first reported a position in BIIB in Q1 2014 and has held it in 14 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Choreo LLC held 2,380 shares of Biogen worth $436K as of Q1 2026.
  • Choreo LLC bought 3 Biogen shares in Q1 2026, an estimated $553.
  • Biogen made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #1019 holding.
  • Choreo LLC first reported a position in Biogen in Q1 2014 and has held it in 14 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.